Patient Portal
Book Online
Call Now !

Full Spectrum Lyme Testing

Lyme disease

Lyme disease, caused by the Borrelia burgdorferi bacterium and transmitted through tick bites, is a complex illness that can manifest in multiple stages. While the early stages often present with flu-like symptoms and a characteristic rash (erythema migrans), if left untreated, the infection can progress and affect various organ systems, including the nervous system. Testing for Lyme disease is crucial for timely diagnosis and treatment to prevent long-term complications.

Importance of Lyme Testing

  • Early Detection and Treatment:
    Lyme testing helps in detecting the infection early, ideally before it spreads to other systems. Early treatment with antibiotics can significantly reduce the risk of chronic complications.
  • Accurate Diagnosis:
    Many of the symptoms of Lyme disease—such as fatigue, joint pain, and cognitive issues—overlap with other conditions (e.g., fibromyalgia, chronic fatigue syndrome, and autoimmune disorders). Testing helps differentiate Lyme from these other illnesses.
  • Preventing Chronic Lyme:
    In some cases, untreated or inadequately treated Lyme disease can progress to a persistent form, sometimes called “chronic Lyme.” Testing, when done correctly, can guide appropriate treatment to prevent the development of these long-term symptoms.
  • Screening for Co-Infections:
    Ticks can carry multiple pathogens, such as Babesia, Anaplasma, and Ehrlichia. Comprehensive Lyme testing may also include screening for these co-infections, which can complicate the clinical picture.
  • Correlation Between Lyme and Neuropsychiatric Presentations
Lyme disease can affect the central and peripheral nervous systems, leading to a range of neurological and psychiatric symptoms. The phenomenon is sometimes referred to as Lyme neuroborreliosis. Here’s how Lyme can influence neuropsychiatric health

01

Cognitive Impairments

Commonly referred to as “Lyme brain,” symptoms include memory loss, difficulty concentrating, and executive dysfunction. These issues may arise due to direct bacterial invasion of the central nervous system or inflammation caused by the immune response

02

Mood Disorders

Lyme disease has been associated with depression, anxiety, irritability, and mood swings. The underlying mechanisms may include immune system dysregulation, neuroinflammation, or the direct effects of the bacteria on brain tissues.

03

Sleep Disturbances

Insomnia, unrefreshing sleep, or altered sleep patterns can occur in individuals with Lyme, potentially exacerbating other neuropsychiatric symptoms.

04

Peripheral Neuropathy

Some patients experience nerve pain, tingling, or burning sensations, which can contribute to psychological distress and affect overall quality of life.

05

Psychosis and Severe Neuropsychiatric Symptoms

In rare cases, untreated Lyme disease can lead to more severe manifestations, such as hallucinations, paranoia, or even suicidal ideation. This underscores the need for prompt and accurate diagnosis.

06

Attention Deficit and Behavioral Changes in Children

Pediatric Lyme disease can manifest with behavioral changes, irritability, and attention deficit, potentially affecting school performance and social interactions.

Challenges in Lyme Testing

  • Testing Limitations:
    Standard two-tiered testing, which includes enzyme-linked immunosorbent assay (ELISA) followed by a Western blot, can sometimes miss early cases. The accuracy of these tests may vary based on the stage of the disease.
  • False Negatives and Positives::
    Early in the disease, the immune system may not yet produce detectable antibodies, leading to false-negative results. On the other hand, antibodies may persist long after the infection has resolved, leading to false positives.
  • Clinical Diagnosis:
    Because of these limitations, Lyme disease is often a clinical diagnosis supported by laboratory tests. Physicians must consider symptoms, potential exposure, and other diagnostic tools like cerebrospinal fluid analysis for neuroborreliosis.

The Importance of a Multidisciplinary Approach

Given the diverse and potentially severe neuropsychiatric symptoms associated with Lyme disease, a multidisciplinary approach that involves infectious disease specialists, neurologists, and mental health professionals can be crucial. This collaboration helps tailor treatments to the individual’s specific presentation, combining antimicrobial therapy with neuropsychiatric interventions when needed.

Lyme disease can significantly

Lyme disease can significantly impact mental health, making it essential to consider this condition in patients presenting with unexplained neuropsychiatric symptoms, especially if there’s a history of tick exposure or residence in Lyme-endemic areas.
The main difference between a full-spectrum Lyme disease test and the standard Western blot lies in the range of bacterial markers they detect and the comprehensiveness of the testing. Here’s a closer look at both

Western Blot Test

The Western blot is part of the traditional two-tiered testing approach for Lyme disease, which typically starts with an initial enzyme-linked immunosorbent assay (ELISA) followed by a confirmatory Western blot if the ELISA is positive or equivocal. Here’s how it works and why it may yield false negatives.
  • How It Works:
    The Western blot detects antibodies against specific proteins of Borrelia burgdorferi, the bacteria that causes Lyme disease. It measures the immune response rather than the presence of the bacteria itself. Two types of antibodies can be measured.
  • IgM antibodies, which appear in the early stages of infection.
  • IgG antibodies, which appear later and persist longer.
  • Limitations Leading to False Negatives:
  • Timing of the Test: If performed too early in the infection, the immune system may not yet have produced detectable levels of antibodies, resulting in a false-negative result.
  • Immune Response Variability: Not everyone produces a strong antibody response, especially if they have a compromised immune system.
  • Interpretation Criteria: The traditional criteria for determining a positive Western blot require a specific number of bands (different bacterial protein antibodies) to be present. If a person’s immune response doesn’t produce antibodies to those specific proteins, the test may come back negative even if they have Lyme disease.
  • Antibiotic Treatment Before Testing: If someone has already started antibiotics before getting tested, it may alter the immune response and potentially reduce the likelihood of detecting antibodies.

Full Spectrum Lyme Disease Testing

Full-spectrum testing goes beyond the traditional two-tier approach by using a more
comprehensive and integrative panel to detect Lyme disease and other tick-borne co-infections.
These tests aim to improve sensitivity and reduce false negatives. Some components of
full-spectrum testing include

  • Expanded Western Blot Panels:
    Some labs offer Western blot tests that look for more Borrelia burgdorferi proteins than the standard version, which may detect additional bands and provide a more sensitive analysis.
  • Polymerase Chain Reaction (PCR):
    PCR tests can detect the genetic material (DNA) of Borrelia in blood, cerebrospinal fluid, or other tissues. This method tests for the presence of the bacteria itself, rather than the immune response, and can sometimes identify an infection even if antibodies are not present.
  • Enzyme Immunoassays for Multiple Strains:
    esting that includes a variety of Borrelia strains and species can help improve detection since Lyme disease can be caused by different types of Borrelia bacteria, especially in Europe or other non-U.S. regions where different strains are prevalent.
  • Coinfection Testing:
    Comprehensive panels may also screen for co-infections from other tick-borne pathogens like Babesia, Anaplasma, Ehrlichia, and Bartonella, which can complicate the clinical picture and often occur alongside Lyme disease.
  • Advanced Immunoassays (e.g., ELISpot):
    ELISpot tests measure T-cell responses to Borrelia antigens, detecting cellular immune responses rather than just antibodies. This can identify an infection even if antibody levels are low.
  • CD57 Natural Killer Cell Count:
    While not a direct test for Lyme, the CD57 count can be used as an indicator of chronic Lyme infection, as lower levels of these cells have been associated with chronic Lyme disease.
  • Key Differences Between Full-Spectrum Testing and Western Blot
  • Range of Detection: Full-spectrum testing includes multiple methods that can detect both antibodies and the bacteria’s DNA, increasing the likelihood of identifying the infection. The Western blot focuses solely on detecting antibodies against specific bacterial proteins.
  • Sensitivity and Specificity: Full-spectrum testing has a higher sensitivity, especially in detecting early-stage or persistent infections, as it can use different testing methodologies. The Western blot may miss cases, especially early in the disease when antibodies are not yet produced, or in chronic cases where the immune response is less pronounced.
  • Comprehensive Coverage: Full-spectrum testing often includes assessments for co-infections, which can influence symptoms and the overall treatment approach. The traditional Western blot does not account for co-infections.

Clinical Implications

Using a full-spectrum approach for Lyme testing can improve the accuracy of diagnosis, particularly in patients with non-specific symptoms, those who may have been infected for a long time, or those with potential co-infections. However, full-spectrum tests may be more expensive and not always covered by insurance. They are also not yet considered the “gold standard” by conventional guidelines, which still rely on the two-tiered ELISA and Western blot method.
Ultimately, considering a patient’s clinical history, symptoms, and potential exposure to ticks is crucial in conjunction with testing for a more accurate diagnosis.

Get In Touch

At Infinity NAD Consulting, we provide expert Psychiatry, NAD+ Therapy, and Ketamine Therapy in Bellevue, WA, offering personalized, evidence-based care tailored to your unique needs and goals

Contact Info

Menu

Legal

Hours

  • Open 7 Days A Week

Locations

DISCLAIMER: NAD+ qualifies as a supplement under FDA guidelines. These statements have not been evaluated by the Food and Drug Administration. Intravenous NAD+ therapy is not intended to diagnose, treat, cure or prevent disease.

Copyright @ 2026 Infinity NAD Consulting, All rights reserved.